Overview of biosimilar medicines in Spain: market dynamics, policies, evidence-based insights and avenues for a sustainable market
{{output}}
Introduction: After 17 years on the market, biosimilar medicines have contributed significantly to the sustainability of healthcare in Spain, providing cost-effective treatment options and savings of more than €1 billion by 2022... ...
